Investigating childhood embryonal tumors in South Egypt
Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience
This study looks at the types and outcomes of childhood tumors in young patients at the South Egypt Cancer Institute to better understand their treatment and effects.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 420 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT02665676 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the demographic and disease characteristics of pediatric patients diagnosed with embryonal tumors at the South Egypt Cancer Institute. It focuses on identifying the prevalence and spectrum of these tumors, which include common types like neuroblastoma, Wilms tumor, and retinoblastoma, as well as rarer forms. The study will review medical records from January 2001 to December 2015 to categorize data based on demographic features, treatment modalities, and outcomes. This comprehensive analysis will help in understanding treatment effectiveness and patient outcomes in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are pediatric patients aged 18 years or younger diagnosed with any type of embryonal neoplasm.
Not a fit: Patients older than 18 years will not benefit from this study as they do not meet the age criteria.
Why it matters
Potential benefit: If successful, this study could enhance understanding of embryonal tumors in children, leading to improved treatment strategies and outcomes.
How similar studies have performed: While this study focuses on a specific regional population, similar studies on embryonal tumors have shown success in identifying treatment outcomes and characteristics in pediatric oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients whose age less than or equal to 18 years. * Patients diagnosed with any of embryonal neoplasms. Exclusion Criteria: • Patients whose age more than 18 years.
Where this trial is running
Assiut
- Assiut University — Assiut, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.